Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sonoma Pharmaceuticals Inc
SNOA
Healthcare
Sonoma Pharmaceuticals, Inc. is a global healthcare company, which is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. The Company's product offerings include Lumacyn Clarifying Mist; Regenacyn Advanced Scar...
Gel; Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel; Microcyn OTC Advanced Wound & Skin Cleanser; Podiacyn Advanced Everyday Foot Care, MicrocynAH and others. Lumacyn Clarifying Mist is intended for use as a daily skin toner, to soothe and cleanse the skin, reduce redness, and manage blemishes by reducing infection. Podiacyn is intended for management of foot odors, infections, and irritations, as well as daily foot health and hygiene. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:SNOA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(271)
•••
whytestocks
X
Post by
whytestocks
on Oct 22, 2024 9:31pm
Sonoma Pharmaceuticals Announces Expanded Partnership with G
BREAKING NEWS: $SNOA Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in CanadaBOULDER, CO / ACCESSWIRE / October 22
...more
(271)
•••
whytestocks
X
Post by
whytestocks
on Sep 17, 2024 1:32pm
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance wit
News; $SNOA Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based SolutionBOULDER, CO / ACCESSWIRE / September 17, 2024 / Sonoma
...more
Redefining Neuroprotection: Revive’s Approach to Treating Brain Injury from Nerve Agents
posted Dec 03, 2024 9:00am by
Revive Therapeutics Ltd
-
|
Evaluating Bucillamine as a potential treatment for nerve agent exposure, in partnership with Defence R&D Canada – Suffield Research Centre (“DRDC”), an agency of the Canadian Department of National Defence. The DRDC is investigating pharmacological compounds, including Bucillamine, that can mitigate nerve agent induced brain injury. ...read more
(9)
•••
MikeTester
X
Post by
MikeTester
on Aug 02, 2024 6:55am
Sonoma Pharmaceuticals (NASDAQ:SNOA) Poised for Growth with
https://beyondspx.com/2024/08/01/sonoma-pharmaceuticals-nasdaqsnoa-poised-for-growth-with-innovative-hypochlorous-acid-products/
(59)
•••
Nibinator
X
Post by
Nibinator
on Dec 05, 2023 1:41pm
Last call at .22
Final rush to .25
(59)
•••
Nibinator
X
Post by
Nibinator
on Dec 05, 2023 6:51am
Try a buy around .26 this morning
High on hopes
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 14, 2023 4:32pm
New Press Release - Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Results
Cash burn of $717,000 for the quarter ended December 31, 2022, 68% less than prior quarter cash burn of $2,235,000Revenues for three and nine months ended December 31, 2022 essentially flat with strong performance in international salesEuropean revenues increased 51% for the quarter and 29% for...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 31, 2023 7:30am
New Press Release - Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea
BOULDER, CO / ACCESSWIRE / January 31, 2023 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including dermatology, eye, oral and...
read article.
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 26, 2023 2:01pm
SNOA .... Vols are light today but it's still trying ; )
The $2.10 target is still a pivot for today A volume spike would be a good catalyst GL
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 25, 2023 4:03pm
SNOA .... 99 million shares traded today....up 49 cents ; )
What a deal..... The Pros really earned their keep today ; )
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 25, 2023 3:54pm
SNOA ...... No Bounce for Bonzo ????
Take a close look at todays 5 min charts on SNOA & FWBI See how similar they are !!!!! Use it to your advantage Cheers ....going skiing !
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 25, 2023 3:42pm
SNOA .... 20 mins til closing
I did say support at $1.60 Let's see what happens
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 25, 2023 2:18pm
SNOA .... Ok ... a trend change on low volume
Next target is $2.10 I'm in !
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 25, 2023 2:08pm
SNOA ....pay no attention to "The Man Behind the Curtain"
No volume.... $1.90 Pfffftttt
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 25, 2023 1:46pm
SNOA ....Strike 3....yer out!!!!!!!!!!!!!!!!!!!
Now we're playing "Spear-catching" Not for everyone because this is dangerous Keeo your powder dry Cheers
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 25, 2023 1:30pm
SNOA .... Now on the "defense".....has to hold $1.83
on this PB..... make note....very low volume right now I smell a rat Support at around $1.60 if it drops Cheers !
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Rig Count Soars as Utilization Surpasses Industry Averages
Learn How this Company is Disrupting Point-of-Care Testing
Unique Battery Metals opportunity in Quebec
Discover Options Trading Strategies to Minimize your Tax Burden
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Debt-Free Cannabis Company Set for Next Stage of Growth